WWMSC
ARCT icon

Wagner Wealth Management (South Carolina)’s Arcturus Therapeutics ARCT Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-121
Closed -$4K – 644
2021
Q2 		$4K Hold
121
– – ﹤0.01% 590
2021
Q1 		$5K Buy
+121
New +$7.21K ﹤0.01% 533

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $38.6B AUM 35.31% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM

Wagner Wealth Management (South Carolina)'s ARCT Position: Q3 2021 in Review

Wagner Wealth Management (South Carolina) sold out of Arcturus Therapeutics (ARCT) in Q3 2021, closing a stake of 121 shares — an estimated $4K sold.

Wagner Wealth Management (South Carolina) first reported a position in ARCT in Q1 2021 and held it in 2 quarters. The position peaked at $5K in Q1 2021. 156 funds tracked by Wall St. Rank hold ARCT as of Q3 2021.

  • Wagner Wealth Management (South Carolina) reported no remaining Arcturus Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 121 Arcturus Therapeutics shares in Q3 2021, an estimated $4K.
  • Wagner Wealth Management (South Carolina) first reported a position in Arcturus Therapeutics in Q1 2021 and held it in 2 quarters.
  • Wagner Wealth Management (South Carolina)'s Arcturus Therapeutics position peaked at $5K in Q1 2021.
  • 156 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2021.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q3 2021, filed 15 Nov 2021.